Anti-Von Willebrand Factor 抗体 [F8/86], prediluted (ab855)

製品の概要

  • 製品名Anti-Von Willebrand Factor antibody [F8/86], prediluted
    Von Willebrand Factor 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [F8/86] to Von Willebrand Factor, prediluted
  • 特異性This antibody reacts with endothelial cells. A positive staining can be seen in the megakaryocytes of human bone marrow.
  • アプリケーション適用あり: IHC-Fr, IHC-Pmore details
  • 種交差性
    交差種: Human
  • 免疫原

    BALB/C mice were injected with Von Willebrand factor isolated from human plasma.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab855 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-Fr
IHC-P
  • 追加情報This antibody has been pretitered and quality controlled to work on formalin-fixed paraffin-embedded as well as acetone fixed cryostat tissue sections.
    No further titration is required.
    We suggest an incubation period of 30-60 minutes at room temperature.
    However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user.
    Enzymatic predigestion with proteolytic enzymes is recommended before immunostaining.
  • ターゲット情報

    • 機能Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.
    • 組織特異性Plasma.
    • 関連疾患Defects in VWF are the cause of von Willebrand disease (VWD) [MIM:277480]. VWD defines a group of hemorrhagic disorders in which the von Willebrand factor is either quantitatively or qualitatively abnormal resulting in altered platelet function. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII and impaired platelet adhesion. Type I von Willebrand disease is the most common form and is characterized by partial quantitative plasmatic deficiency of an otherwise structurally and functionally normal Willebrand factor; type II is associated with a qualitative deficiency and functional anomalies of the Willebrand factor; type III is the most severe form and is characterized by total or near-total absence of Willebrand factor in the plasma and cellular compartments, also leading to a profound deficiency of plasmatic factor VIII.
    • 配列類似性Contains 1 CTCK (C-terminal cystine knot-like) domain.
      Contains 4 TIL (trypsin inhibitory-like) domains.
      Contains 3 VWFA domains.
      Contains 3 VWFC domains.
      Contains 4 VWFD domains.
    • ドメインThe von Willebrand antigen 2 is required for multimerization of vWF and for its targeting to storage granules.
    • 翻訳後修飾All cysteine residues are involved in intrachain or interchain disulfide bonds.
      N- and O-glycosylated.
    • 細胞内局在Secreted. Secreted > extracellular space > extracellular matrix. Localized to storage granules.
    • Information by UniProt
    • 参照データベース
    • 別名
      • Coagulation factor VIII antibody
      • Coagulation factor VIII VWF antibody
      • F8VWF antibody
      • Factor VIII related antigen antibody
      • von Willebrand antigen 2 antibody
      • von Willebrand antigen II antibody
      • Von Willebrand disease antibody
      • VWD antibody
      • vWF antibody
      • VWF_HUMAN antibody
      see all

    Anti-Von Willebrand Factor antibody [F8/86], prediluted (ab855) 使用論文

    ab855 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab855.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"